Brookfield Corp’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-115,089
Closed -$932K 601
2023
Q1
$932K Buy
+115,089
New +$924K ﹤0.01% 515
2021
Q4
Sell
-119,893
Closed -$3.34M 635
2021
Q3
$3.34M Sell
119,893
-133,458
-53% -$3.78M 0.01% 273
2021
Q2
$7.43M Buy
253,351
+186,804
+281% +$5.66M 0.03% 164
2021
Q1
$2.11M Sell
66,547
-10,511
-14% -$308K 0.01% 277
2020
Q4
$1.6M Buy
+77,058
New +$1.44M 0.01% 314
2017
Q1
Sell
-73,189
Closed -$1.06M 155
2016
Q4
$1.06M Sell
73,189
-1,843
-2% -$33.8K 0.01% 156
2016
Q3
$1.84M Sell
75,032
-25,145
-25% -$651K 0.01% 137
2016
Q2
$2.01M Sell
100,177
-121,756
-55% -$3.45M 0.01% 148
2016
Q1
$5.82M Sell
221,933
-5,672
-2% -$419K 0.03% 107
2015
Q4
$23.1M Buy
+227,605
New +$25.6M 0.13% 63

Other funds holding BHC

Brookfield Corp's BHC Position: Q2 2023 in Review

Brookfield Corp sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 115,089 shares — an estimated $932K sold.

Brookfield Corp first reported a position in BHC in Q4 2015 and held it in 10 quarters. The position peaked at $23.1M in Q4 2015. 231 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

  • Brookfield Corp reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 115,089 Bausch Health shares in Q2 2023, an estimated $932K.
  • Brookfield Corp first reported a position in Bausch Health in Q4 2015 and held it in 10 quarters.
  • Brookfield Corp's Bausch Health position peaked at $23.1M in Q4 2015.
  • 231 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.